[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267 225 7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeffrey  Liebman", "title": "Associate Director of Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.13, "open": 1.14, "dayLow": 1.052, "dayHigh": 1.15, "regularMarketPreviousClose": 1.13, "regularMarketOpen": 1.14, "regularMarketDayLow": 1.052, "regularMarketDayHigh": 1.15, "payoutRatio": 0.0, "beta": 1.932, "forwardPE": -3.758621, "volume": 216890, "regularMarketVolume": 216890, "averageVolume": 290589, "averageVolume10days": 442230, "averageDailyVolume10Day": 442230, "bid": 1.06, "ask": 1.12, "bidSize": 2, "askSize": 1, "marketCap": 97777576, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.326, "allTimeHigh": 10.87, "allTimeLow": 0.47, "fiftyDayAverage": 1.04436, "twoHundredDayAverage": 0.83517, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14427843, "profitMargins": 0.0, "floatShares": 37696393, "sharesOutstanding": 89704194, "sharesShort": 465787, "sharesShortPriorMonth": 506955, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0052, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.76459, "shortRatio": 1.26, "shortPercentOfFloat": 0.0063, "impliedSharesOutstanding": 89704194, "bookValue": 0.92, "priceToBook": 1.1847826, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -34207572, "trailingEps": -0.43, "forwardEps": -0.29, "enterpriseToEbitda": -0.377, "52WeekChange": -0.5112108, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.16667, "targetMedianPrice": 4.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 83517048, "totalCashPerShare": 0.931, "ebitda": -38285488, "totalDebt": 167319, "quickRatio": 18.333, "currentRatio": 19.087, "debtToEquity": 0.203, "returnOnAssets": -0.25215, "returnOnEquity": -0.37252998, "freeCashflow": -37020280, "operatingCashflow": -17703620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Context Therapeutics Inc.", "shortName": "Context Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1761953904, "regularMarketTime": 1761940801, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -3.53982, "regularMarketPrice": 1.09, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "postMarketChangePercent": 3.6697211, "postMarketPrice": 1.13, "postMarketChange": 0.03999996, "regularMarketChange": -0.04, "regularMarketDayRange": "1.052 - 1.15", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 290589, "fiftyTwoWeekLowChange": 0.6, "fiftyTwoWeekLowChangePercent": 1.2244898, "fiftyTwoWeekRange": "0.49 - 2.326", "fiftyTwoWeekHighChange": -1.236, "fiftyTwoWeekHighChangePercent": -0.53138435, "fiftyTwoWeekChangePercent": -51.12108, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.43, "epsForward": -0.29, "epsCurrentYear": -0.3175, "priceEpsCurrentYear": -3.4330711, "fiftyDayAverageChange": 0.04563999, "fiftyDayAverageChangePercent": 0.043701395, "twoHundredDayAverageChange": 0.25483006, "twoHundredDayAverageChangePercent": 0.3051236, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]